This site is intended only for healthcare professionals resident in India

Search

Menu

Close

Sign InLog Out
Our medicinesTherapy areasExplore ContentExplore contentEventsMaterialsVideosLet's connectLet's ConnectPfizer medical informationOnConnect

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

AboutEfficacySafetyDosingPortfolioSupportGroAssistEventsMaterialsVideos
Convenient, once-weekly administration1,2A multidose, disposable pen that is prefilled and ready to use, with no reconstitution required1

See below for an overview of GENRYZON dosing and administration steps.

DOSING OVERVIEW1
  • Once-weekly dosing is based on weight—0.66 mg/kg of body weight administered once weekly by subcutaneous injection 
  • No dose recommendations can be made for patients with hepatic or renal impairment as GENRYZON has not been studied in these patients 
ADMINISTRATION1,3

Refer to full Instructions for Use for detailed steps.

  • Patients should administer GENRYZON once weekly, on the same day each week, at any time of the day
  • The day of weekly administration can be changed if necessary as long as the time between two doses is at least 3 days (>72 hours)
  • GENRYZON can be given in the abdomen, thighs, buttocks, or upper arms. The site of injection should be rotated at each administration
  • If more than one injection is required to deliver a complete dose, each injection should be administered at a different injection site

Getting ready

  • Wash and dry your hands
  • Use the pen straight from the refrigerator or leave it at room temperature for up to 30 minutes for a more comfortable injection

Choose and clean your injection site

  • Injection should be given in the abdomen (belly), thighs, buttocks, or upper arms
  • Select a different site for each injection
  • Do not inject into bony areas, areas that are bruised, red, sore, or have scars or skin conditions
  • Clean the injection site with an alcohol swab and let dry. Do not touch injection site after cleaning

Prepare your injection

  • Pull off the pen cap and set it aside for after the injection. Check that the medicine is colorless to slightly light yellow and is free of flakes or particles
  • Take a new needle and pull off its protective foil. Attach a new needle for each injection
  • Pull off the outer needle cover. Set it aside for later to help remove the needle
  • Pull off the inner needle cap. Throw away inner needle cap in a sharps container

Set your prescribed dose

  • Turn the knob to set your dose; dose knob turns 0.5 mg at a time for the GENRYZON 60-mg pen and 0.2 mg at a time for the GENRYZON 24-mg pen
  • Check the dose window to make sure you have set the correct dose
  • If your dose is more than 30 mg when using the GENRYZON 60-mg pen, or more than 12 mg when using the GENRYZON 24-mg pen, you will need more than 1 injection. Use a new needle for each injection

Inject your dose

  • Hold the pen so you can see the numbers in the dose window
  • Insert the needle straight into your skin
  • Press the injection button until it can’t go down any further and “0” is displayed in the dose window. Hold the button down for 10 seconds, then let go of the injection button and remove the pen from the injection site by pulling the needle straight out

Finish up

  • Carefully replace the outer needle cover
  • Unscrew the capped needle and dispose of it in a sharps container
  • Do not reuse needles
  • Replace the pen cap. If there is any medicine left, store it in the refrigerator between uses

If setting up the first use of new pen:

  • Turn the dose knob to 1.0 for the 60-mg pen; for the 24-mg pen, set dose knob to 0.4
  • Hold the pen with the needle pointing up. Tap cartridge holder gently to float any air bubbles to the top
  • Press the injection button until it cannot go any further and you see “0” in the dose window. If liquid appears at needle tip, the pen is set up. If liquid has not appeared, repeat first-use steps
How to use GENRYZON

Step-by-step video tutorial on how to prepare and give an injection with the GENRYZON prefilled pen. You can also download the complete Instructions for Use here.

Consider GENRYZON for all your appropriate patients age 3 years and older with pediatric GH deficiency1

Learn more about GENRYZON Efficacy and Safety

References:Adapted from GENRYZONTM Local Product Document: LPDGEN092022.Maniatis AK, Carakushansky M, Galcheva S, et al. Perception of treatment burden with once weekly somatrogon vs once daily Genotropin in pediatric patients with growth hormone deficiency: results from a randomized phase 3 study. Poster 6895 presented at: Annual Meeting of the Endocrine Society [virtual]; March 20-23, 2021.GENRYZON™ Package Leaflet.Zadik Z, Zelinska N, Iotova V, et al. Results from an open-label extension of the phase 2 dose-finding study of once weekly somatrogon vs daily Genotropin in pediatric patients with growth hormone deficiency (GHD). Poster 6887 presented at: Annual Meeting of the Endocrine Society [virtual]; March 20-23, 2021.



 

PP-SMT-IND-0027,  05 OCT 2023

 

EFFICACY

Height outcome comparable to daily growth hormone (GH) in children with GH deficiency...with the benefit of fewer injections.1

View efficacy data
SAFETY

5 years of clinical safety data in children with GH deficiency.4

View safety data
Contact Center for Health Care Professionals | Monday to Saturday 9:00 AM to 6:00 PM IST(exlcuding public holidays)

0008000503188

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out
These pages are not intended for patients or for members of the general public. The web pages contain promotional content. For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Full prescribing information available on request. For more details on, Who is a Registered Medical Practitioner, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April2021.

Address: The Capital,  A Wing, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra Kurla Complex, Bandra East, Mumbai – 400051, India.
PP-SMT-IND-0027

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

ButtonButton

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.

Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.

Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.

Copyright © 2024 Pfizer Limited, India. All rights reserved. Applicable for Pfizer Products, Product Microsites and Therapy Areas section of the website:
  • All content published herein is intended and strictly only for informational, educational, academic and/or research purposes and shall not be utilized to diagnose or treat a health problem or disease without referring to the full prescribing information for list of approved indications as contained in the product package insert
  • While due care and caution has been taken to ensure that the content herein is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information herein
For the use only of Registered medical practitioners* or a Hospital or a Laboratory

These pages are not intended for patients or for members of the general public. The web pages contain promotional content.

 

If you select 'No', you will be redirected to Pfizer.co.in

For more details on, Who is a Registered medical practitioner*, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.


PP-DOL-IND-0642  28 May 2024
Yes No
You are now leaving PfizerPro website

​​​​​You are now leaving Pfizer Pro website and will be redirected to another website. Note that you will be governed by the Terms & Conditions and Privacy Policy of the external website. Would you like to continue?
PP-DOL-IND-0642  28 May 2024